Search results
Bitcoin Price Prediction: $150K Forecast and ETF Market Trends; BTC to Hit $70,000?
Cryptonews· 23 hours agoBitcoin price climb to $68,733, fueled by a $150,000 prediction and strong ETF market activity,...
AbbVie Skyrizi Gets CHMP Nod for Ulcerative Colitis in EU - AbbVie (NYSE:ABBV), ALX Oncology...
Benzinga· 11 hours agoAbbVie ABBV announced that the Committee for Medicinal Products for Human Use (CHMP) of the European...
Cardano (ADA) in Dire State, Shiba Inu (SHIB) Needs Some Help, Ethereum (ETH) Dominance Continues
Investing.com· 6 days agoIn its current state, Cardano is clearly having some serious issues, with ADA struggling to maintain...
EMA and Alabama Power: Start preparing now for 2024 hurricane season
WBRC Fox 6 Birmingham· 5 days agoWe are just days away from the official start of hurricane season. EMA and Alabama Power say that...
'The Strangers: Chapter 1' Surpasses a Frighteningly Strong $30 Million at the Global Box Office
Collider· 15 hours agoAfter a strong domestic opening that saw the movie earn $15 million worldwide in just a week, The...
EU regulator backs use of Pfizer's gene therapy for rare bleeding disorder
Reuters via Yahoo News· 4 days agoThe regulator has recommended granting a 'conditional marketing authorization,' which is for the...
EMA Authorizes Hemophilia B Gene Therapy
Medscape· 4 days agoThe European Medicines Agency has given the go-ahead for Durveqtix to treat hemophilia B in adults and to Adzynma for patients with congenital thrombotic thrombocytopenic purpura.
Meet the New Actor Playing Adar in New 'Rings of Power' Season 2 Images
Collider· 12 hours agoOrc leader Adar gets a brand-new look in the Prime Video series, The Lord of the Rings: The Rings of...
Clark County to form reunification team, train this week
Springfield News-Sun· 22 hours agoThe EMA entered into a $17,500 agreement with the I Love U Guys Foundation, which trains responders,...
Small Business - Picayune Item | Picayune Item
The Picayune Item· 2 days agoCStone Announces European Medicine Agency CHMP Recommends Approval of Cejemly® (sugemalimab, anti-PD-L1) as First-Line Treatment for NSCLC PR Newswire SUZHOU, China, June 1, 2024 EMA ...
